Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome
- PMID: 30262806
- PMCID: PMC6160438
- DOI: 10.1038/s41467-018-06485-7
Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome
Abstract
To evaluate the potential of an integrated clinical test to detect diverse classes of somatic and germline mutations relevant to pediatric oncology, we performed three-platform whole-genome (WGS), whole exome (WES) and transcriptome (RNA-Seq) sequencing of tumors and normal tissue from 78 pediatric cancer patients in a CLIA-certified, CAP-accredited laboratory. Our analysis pipeline achieves high accuracy by cross-validating variants between sequencing types, thereby removing the need for confirmatory testing, and facilitates comprehensive reporting in a clinically-relevant timeframe. Three-platform sequencing has a positive predictive value of 97-99, 99, and 91% for somatic SNVs, indels and structural variations, respectively, based on independent experimental verification of 15,225 variants. We report 240 pathogenic variants across all cases, including 84 of 86 known from previous diagnostic testing (98% sensitivity). Combined WES and RNA-Seq, the current standard for precision oncology, achieved only 78% sensitivity. These results emphasize the critical need for incorporating WGS in pediatric oncology testing.
Conflict of interest statement
The authors declare no competing interests.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6160438/bin/41467_2018_6485_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6160438/bin/41467_2018_6485_Fig2_HTML.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6160438/bin/41467_2018_6485_Fig3_HTML.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6160438/bin/41467_2018_6485_Fig4_HTML.gif)
![Fig. 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6160438/bin/41467_2018_6485_Fig5_HTML.gif)
![Fig. 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6160438/bin/41467_2018_6485_Fig6_HTML.gif)
Similar articles
-
Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer.Methods. 2015 Jul 15;83:118-27. doi: 10.1016/j.ymeth.2015.04.016. Epub 2015 Apr 23. Methods. 2015. PMID: 25913717 Free PMC article.
-
Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5473-8. doi: 10.1073/pnas.1418631112. Epub 2015 Mar 31. Proc Natl Acad Sci U S A. 2015. PMID: 25827230 Free PMC article.
-
Analytical validation of whole exome and whole genome sequencing for clinical applications.BMC Med Genomics. 2014 Apr 23;7:20. doi: 10.1186/1755-8794-7-20. BMC Med Genomics. 2014. PMID: 24758382 Free PMC article.
-
Exome versus transcriptome sequencing in identifying coding region variants.Expert Rev Mol Diagn. 2012 Apr;12(3):241-51. doi: 10.1586/erm.12.10. Expert Rev Mol Diagn. 2012. PMID: 22468815 Review.
-
Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies.Curr Opin Allergy Clin Immunol. 2012 Dec;12(6):623-8. doi: 10.1097/ACI.0b013e3283588ca6. Curr Opin Allergy Clin Immunol. 2012. PMID: 23095910 Review.
Cited by
-
SMARCA4-deficient primary bone sarcoma with "teratoid" features in a rhabdoid tumor predisposition syndrome patient.Virchows Arch. 2024 Aug 7. doi: 10.1007/s00428-024-03887-5. Online ahead of print. Virchows Arch. 2024. PMID: 39112597 No abstract available.
-
[Molecular pathological analysis through the ages].Pathologie (Heidelb). 2024 May;45(3):173-179. doi: 10.1007/s00292-024-01326-5. Epub 2024 Apr 15. Pathologie (Heidelb). 2024. PMID: 38619582 Free PMC article. Review. German.
-
Single nucleotide variants in nuclear pore complex disassembly pathway associated with poor survival in osteosarcoma.Front Genet. 2024 Mar 18;15:1303404. doi: 10.3389/fgene.2024.1303404. eCollection 2024. Front Genet. 2024. PMID: 38562379 Free PMC article.
-
A systematic pan-cancer study on deep learning-based prediction of multi-omic biomarkers from routine pathology images.Commun Med (Lond). 2024 Mar 15;4(1):48. doi: 10.1038/s43856-024-00471-5. Commun Med (Lond). 2024. PMID: 38491101 Free PMC article.
-
Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 Fusion.Leukemia. 2024 May;38(5):981-990. doi: 10.1038/s41375-024-02194-x. Epub 2024 Mar 1. Leukemia. 2024. PMID: 38429501
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous